BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: O’Connor KS, George J, Booth D, Ahlenstiel G. Dendritic cells in hepatitis C virus infection: Key players in the IFNL3-genotype response. World J Gastroenterol 2014; 20(47): 17830-17838 [PMID: 25548481 DOI: 10.3748/wjg.v20.i47.17830]
URL: https://www.wjgnet.com/1007-9327/full/v20/i47/17830.htm
Number Citing Articles
1
Bassem Refaat, Ahmed Mohamed Ashshi, Adel Galal El-Shemi, Esam Azhar. Activins and Follistatin in Chronic Hepatitis C and Its Treatment with Pegylated-Interferon-αBased TherapyMediators of Inflammation 2015; 2015: 1 doi: 10.1155/2015/287640
2
Giulia Finotti, Nicola Tamassia, Federica Calzetti, Giovanna Fattovich, Marco A Cassatella. Endogenously produced TNF-α contributes to the expression of CXCL10/IP-10 in IFN-λ3-activated plasmacytoid dendritic cellsJournal of Leukocyte Biology 2016; 99(1): 107 doi: 10.1189/jlb.3VMA0415-144R
3
Karina González-Aldaco, Luis A. Torres-Reyes, Claudia Ojeda-Granados, Alexis José-Ábrego, Nora A. Fierro, Sonia Román. Immunometabolic Effect of Cholesterol in Hepatitis C Infection: Implications in Clinical Management and Antiviral TherapyAnnals of Hepatology 2018; 17(6): 908 doi: 10.5604/01.3001.0012.7191
4
Г.В. Волынец. Features of Lipid Metabolism in HCV InfectionКлиническая инфектология и паразитология 2021; (4): 412 doi: 10.34883/PI.2020.9.4.028
5
Yi-Fan Lu, David M. Mauger, David B. Goldstein, Thomas J. Urban, Kevin M. Weeks, Shelton S. Bradrick. IFNL3 mRNA structure is remodeled by a functional non-coding polymorphism associated with hepatitis C virus clearanceScientific Reports 2015; 5(1) doi: 10.1038/srep16037
6
Marion Depla, Sandy Pelletier, Nathalie Bédard, Camille Brunaud, Julie Bruneau, Naglaa H. Shoukry. IFN‐λ3 polymorphism indirectly influences NK cell phenotype and function during acute HCV infectionImmunity, Inflammation and Disease 2016; 4(3): 376 doi: 10.1002/iid3.122
7
Yi-Ping Hung, Yu-Yun Shao, Chiun Hsu, Chih-Hung Hsu, Jan-Mou Lee, Muh-Hwa Yang, Yee Chao. The unique characteristic in peripheral immune cells in patients with advanced hepatocellular carcinomaJournal of the Formosan Medical Association 2021; 120(8): 1581 doi: 10.1016/j.jfma.2020.11.015